- Home
- XNCR vs FINS Comparison
XNCR vs FINS Comparison
Compare XNCR & FINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- FINS
- Stock Information
- Founded
- XNCR 1997
- FINS 2019
- Country
- XNCR United States
- FINS United States
- Employees
- XNCR N/A
- FINS N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- FINS Finance/Investors Services
- Sector
- XNCR Health Care
- FINS Finance
- Exchange
- XNCR Nasdaq
- FINS Nasdaq
- Market Cap
- XNCR 547.8M
- FINS 443.4M
- IPO Year
- XNCR 2013
- FINS N/A
- Fundamental
- Price
- XNCR $8.62
- FINS $13.43
- Analyst Decision
- XNCR Buy
- FINS
- Analyst Count
- XNCR 10
- FINS 0
- Target Price
- XNCR $23.33
- FINS N/A
- AVG Volume (30 Days)
- XNCR 726.1K
- FINS 78.0K
- Earning Date
- XNCR 11-05-2025
- FINS 01-01-0001
- Dividend Yield
- XNCR N/A
- FINS 9.97%
- EPS Growth
- XNCR N/A
- FINS N/A
- EPS
- XNCR N/A
- FINS N/A
- Revenue
- XNCR $146,929,000.00
- FINS N/A
- Revenue This Year
- XNCR $22.06
- FINS N/A
- Revenue Next Year
- XNCR N/A
- FINS N/A
- P/E Ratio
- XNCR N/A
- FINS N/A
- Revenue Growth
- XNCR N/A
- FINS N/A
- 52 Week Low
- XNCR $6.92
- FINS $11.61
- 52 Week High
- XNCR $27.24
- FINS $12.57
- Technical
- Relative Strength Index (RSI)
- XNCR 55.91
- FINS 66.11
- Support Level
- XNCR $8.25
- FINS $13.20
- Resistance Level
- XNCR $8.73
- FINS $13.37
- Average True Range (ATR)
- XNCR 0.37
- FINS 0.11
- MACD
- XNCR 0.06
- FINS 0.01
- Stochastic Oscillator
- XNCR 69.03
- FINS 80.00
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About FINS Angel Oak Financial Strategies Income Term Trust of Beneficial Interest
Angel Oak Financial Strats Income Term is a non-diversified, closed-end management investment company. The fund's objective is to seek current income with a secondary objective of total return. In pursuing its investment objective, the fund invests mainly in debt issued by financial institutions, including subordinated debt, unrated debt, senior debt, and high-yield securities.